Sphera Funds Management »

Freeline Therapeutics Holdings shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Freeline Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Freeline Therapeutics Holdings held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Freeline Therapeutics Holdings by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $105k 16k 6.37

More positions owned by Sphera Funds Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Sanofi Sponsored Adr (SNY)
Cytokinetics Com New (CYTK)
NOVA MEASURING Instruments L (NVMI)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Tower Semiconductor Shs New (TSEM)
Nice Sponsored Adr (NICE)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Astrazeneca Sponsored Adr (AZN)
Biogen Idec (BIIB)
Bridgebio Pharma (BBIO)

View all positions for Sphera Funds Management

Top funds holding Freeline Therapeutics Holdings

UBS Group
Blue Owl Capital Holdings
Jpmorgan Chase & Co
PenderFund Capital Management
Harbor Capital Advisors
Sphera Funds Management
Rhumbline Advisers

View all funds holding Freeline Therapeutics Holdings